3-((tert-Butoxycarbonyl)amino)-3-(p-tolyl)propanoic acid, 98%, 250mg

2'-Aminoacetanilide>98.0%(T)5g

(S)-2-((tert-butoxycarbonyl)(methyl)amino)-3-methyl-3-phenylbutanoic acid, 98%, 100mg

1-Nonanol>99.0%(GC)500mL

2-Amino-3-(3,5-dichlorophenyl)propanoic acid, 98%, 5g

N-Boc-Iminodipropionic acid, 98.0%, 5g

3-(naphthalen-1-yl)-1,2-oxazol-5-ol, 95.0%, 2g

9-Fluorenylmethyl Chloroformate [N-Protecting Agent for Peptides Research]>97.0%(HPLC)(T)5g

4-(4-Methylpiperazino)aniline, 97.0%, 5g

2,2-Bis((4R,5S)-4,5-diphenyl-4,5-dihydrooxazol-2-yl)acetonitrile, 97%, 250mg

Tert-butyl (2R,3R)-2,3-dimethylpiperazine-1-carboxylate, 98%, 100mg

Gallic acid monohydrate, min. 99%, 500 g, plastic packaging.

Mizoribine, 95%, 250mg